http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2708442-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfcd52f7e5daaa5c12bdc3a8384619c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
filingDate 2003-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b284e3eb40009dd39024594806cfde28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2dbc5ce5a2aa717258d147762d87a89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f52c4e8a54b6329060f4d48fa178f09b
publicationDate 2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2708442-A1
titleOfInvention A process for preparing n-(2-halo-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide, an intermediate of nevirapine
abstract A process for making nevirapine, comprising the following steps: (a) reacting a 2-halo-3-pyridinecarbonitrile of the formula (I), wherein X is a fluorine, chlorine, bromine or iodine atom, preferably chlorine or bromine, with cyclopropylamine, to yield 2-(cyclopropylamino)-3-pyridinecarbonitrile; (b) hydrolyzing the 2-(cyclopropylamino)-3-pyridinecarbonitrile to yield 2-(cyclopropylamino)-3-pyridine carboxylic acid; (c) isolating the 2-(cyclopropylamino)-3-pyridine carboxylic acid from the reaction medium; (e) treating the 2-(cyclopropylamino)-3-pyridine carboxylic acid with a chlorinating agent, to yield 2-(cyclopropylamino)-3-pyridinecarbonyl chloride; (f) reacting the 2-(cyclopropylamino)-3-pyridine carbonyl chloride with a 2-halo-4-methyl-3-pyridinamine of the formula (I), wherein X is a fluorine, chlorine, bromine or iodine atom, preferably chlorine or bromine, to produe an N-(2-halo-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide; and (g) cyclizing the N-(2-halo-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide by treatment with a strong base, to yield nevirapine.
priorityDate 2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421141425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11513793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421141428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426179611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457560897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10375446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10035163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516

Total number of triples: 45.